HRT Financial’s Niagen Bioscience, Inc. Common Stock NAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-130,845
| Closed | -$455K | – | 3103 |
|
|
2024
Q1 | $455K | Buy |
130,845
+118,243
| +938% | +$411K | ﹤0.01% | 1252 |
|
|
2023
Q4 | $18K | Buy |
+12,602
| New | +$18K | ﹤0.01% | 1879 |
|
|
2023
Q3 | – | Sell |
-17,745
| Closed | -$27K | – | 2977 |
|
|
2023
Q2 | $27K | Buy |
+17,745
| New | +$27K | ﹤0.01% | 1877 |
|
|
2022
Q3 | – | Sell |
-37,787
| Closed | -$63K | – | 3462 |
|
|
2022
Q2 | $63K | Buy |
+37,787
| New | +$63K | ﹤0.01% | 2409 |
|
|
2020
Q4 | – | Sell |
-10,575
| Closed | -$42K | – | 2508 |
|
|
2020
Q3 | $42K | Buy |
+10,575
| New | +$42K | ﹤0.01% | 1619 |
|